Search results for "Patient Dropouts"

showing 7 items of 17 documents

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

2018

In this independent, multicenter, retrospective study, we investigated the short-term persistence to treatment with first-line self-injectable or oral disease-modifying treatments (DMTs) in patients with relapsing–remitting multiple sclerosis. Data of patients regularly attending 21 Italian MS Centres who started a self-injectable or an oral DMT in 2015 were collected to: (1) estimate the proportion of patients discontinuing the treatment; (3) explore reasons for discontinuation; (3) identify baseline predictors of treatment discontinuation over a follow-up period of 12 months. We analyzed data of 1832 consecutive patients (1289 women, 543 men); 374 (20.4%) of them discontinued the prescrib…

MaleInjectionTime FactorsPatient Dropoutdisease-modifying therapies; multiple sclerosis; outcome measurement; persistence to treatment; quality of lifeAdministration OralSelf AdministrationSex FactorKaplan-Meier EstimateRelapsing-Remittingmultiple sclerosisImmunologic Factor0302 clinical medicineQuality of lifeRetrospective StudieRisk FactorsMedicine030212 general & internal medicineDisease-modifying therapiedisease-modifying therapiesDisease-modifying therapies Multiple sclerosis Outcome measurement Persistence to treatment Quality of life Administration Oral Adult; Female Follow-Up Studies Humans Immunologic Factors Injections Kaplan-Meier EstimateMale Multiple Sclerosis Relapsing-Remitting Patient Dropouts Prognosis Proportional Hazards Models Retrospective Studies Risk Factors Self Administration Sex Factors Time FactorsHazard ratioPrognosisNeurologyTolerabilityAdministrationSettore MED/26 - NeurologiaFemaleoutcome measurementHumanOralAdultmedicine.medical_specialtyPatient DropoutsTime FactorPrognosiFollow-Up StudieInjections03 medical and health sciencesRoute of administrationMultiple Sclerosis Relapsing-RemittingSex FactorsInternal medicineHumansImmunologic FactorsMultiple sclerosiAdverse effectProportional Hazards ModelsRetrospective Studiesbusiness.industryProportional hazards modelRisk FactorRetrospective cohort studyDiscontinuationDisease-modifying therapies; Multiple sclerosis; Outcome measurement; Persistence to treatment; Quality of life; Administration Oral; Adult; Female; Follow-Up Studies; Humans; Immunologic Factors; Injections; Kaplan-Meier Estimate; Male; Multiple Sclerosis Relapsing-Remitting; Patient Dropouts; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Self Administration; Sex Factors; Time Factorsquality of lifeProportional Hazards Modelpersistence to treatmentNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up StudiesJournal of neurology
researchProduct

One size doesn’t fit all: a thematic analysis of interviews with people who have stopped participating in Narcotics Anonymous in Norway

2020

Abstract Background For persons with substance use disorders (SUDs), 12-step groups (TSGs) are the most available and used peer-based recovery resource, worldwide. However, disengagement is common, and attrition may partly be due to practices and procedures within these groups that are unacceptable to a portion of the population with SUDs. Our overall aim was to identify problematic issues related to Narcotics Anonymous (NA) participation in Norway, to inform addiction professionals’ strategies when referring persons to addiction-related self-help groups (SHGs). Methods In this qualitative study, we interviewed ten individuals who had previously participated regularly in NA for at least 6 m…

MaleNarcoticsSelf-help groupsmedicine.medical_specialtylcsh:Social pathology. Social and public welfare. CriminologyPatient DropoutsSubstance-Related Disordersmedia_common.quotation_subjectPopulationExplanatory model030508 substance abuseNarcotics anonymousorganizationlcsh:HV1-9960Interviews as Topic03 medical and health sciences0302 clinical medicineorganization.foundermedicineHumansVDP::Medisinske Fag: 700030212 general & internal medicineDisengagement theoryeducationPsychiatryQualitative ResearchSubstance use disordersmedia_commonlcsh:R5-920education.field_of_studyNorwayResearchAddictionGeneral MedicineMiddle AgedHealth psychologyNarcotics AnonymousFemaleThematic analysislcsh:Medicine (General)0305 other medical sciencePsychologyQualitative researchAddiction Science & Clinical Practice
researchProduct

Effects of morning versus evening combined strength and endurance training on physical performance, muscle hypertrophy, and serum hormone concentrati…

2016

This study investigated the effects of 24 weeks of morning versus evening same-session combined strength (S) and endurance (E) training on physical performance, muscle hypertrophy, and resting serum testosterone and cortisol diurnal concentrations. Forty-two young men were matched and assigned to a morning (m) or evening (e) E + S or S + E group (mE + S, n = 9; mS + E, n = 9; eE + S, n = 12; and eS + E, n = 12). Participants were tested for dynamic leg press 1-repetition maximum (1RM) and time to exhaustion (Texh) during an incremental cycle ergometer test both in the morning and evening, cross-sectional area (CSA) of vastus lateralis and diurnal serum testosterone and cortisol concentrati…

MaleTime FactorsHydrocortisonePhysiologyEndocrinology Diabetes and MetabolismMuscle DevelopmentQuadriceps MuscleMuscle hypertrophy0302 clinical medicineTestosteroneLeg pressFatigueTestosteroneMorningNutrition and DieteticsGeneral MedicineCircadian Rhythmconcurrent trainingorder effecttime-of-dayAdultmedicine.medical_specialtyPatient DropoutsEveningWeight LiftingAthletic Performancecortisol03 medical and health sciencesEndurance trainingPhysiology (medical)Internal medicinemedicineHumansMuscle StrengthMuscle SkeletalExercisebusiness.industryResistance TrainingHypertrophy030229 sport sciencesmuscle cross-sectional areaBicyclingEndocrinologyPhysical performanceExercise TestPhysical Endurancetestosteronibusiness030217 neurology & neurosurgeryHormoneApplied Physiology, Nutrition, and Metabolism
researchProduct

More Likely to Dropout, but What if They Don’t? Partner Violence Offenders With Alcohol Abuse Problems Completing Batterer Intervention Programs

2018

There is general consensus that alcohol abuse is a risk factor to be considered in batterer intervention programs. Intimate partner violence perpetrators with alcohol abuse problems are more likely to dropout of batterer intervention programs. However, there is little research on intimate partner violence perpetrators with alcohol abuse problems completing batterer intervention programs. In this study, we analyze drop-out rates among perpetrators with alcohol abuse problems and explore whether perpetrators with alcohol abuse problems completing a batterer intervention program differ from those who do not have alcohol abuse problems in a number of outcomes. The sample was 286 males convicte…

Malemedicine.medical_specialtyPatient DropoutsIntimate Partner ViolenceAlcohol abuseSocial integrationIntervention (counseling)medicineHumans0501 psychology and cognitive sciencesRisk factorPsychiatryApplied PsychologyRecidivism050901 criminology05 social sciencesfood and beveragesCriminalsmedicine.diseaseTest (assessment)AlcoholismClinical PsychologyDomestic violence0509 other social sciencesAttributionPsychology050104 developmental & child psychologyClinical psychologyJournal of Interpersonal Violence
researchProduct

Predictors of early dropout in treatment for gambling disorder: The role of personality disorders and clinical syndromes

2017

Several treatment options for gambling disorder (GD) have been tested in recent years; however dropout levels still remain high. This study aims to evaluate whether the presence of psychiatric comorbidities predicts treatment outcome according to Millon's evolutionary theory, following a six-month therapy for GD. The role of severity, duration of the disorder, typology of gambling (mainly online or offline) and pharmacological treatment were also analysed. The recruitment included 194 pathological gamblers (PGs) to be compared with 78 healthy controls (HCs). Psychological assessment included the South Oaks Gambling Screen and the Millon Clinical Multiaxial Inventory-III. The "treatment fail…

TypologyAdultMalemedicine.medical_specialtyPatient DropoutsAdolescentSubstance-Related Disorders030508 substance abuseComorbidityPersonality DisordersStress Disorders Post-Traumatic03 medical and health sciencesYoung Adult0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansPsychological testingTreatment FailurePsychiatryPathologicalSettore MED/25 - PsichiatriaBiological PsychiatryDropout (neural networks)AgedAntisocial personality disorderAntisocial Personality DisorderSyndromeMiddle Agedmedicine.diseasePersonality disorders030227 psychiatryPsychotherapyPsychiatry and Mental healthPassive-Aggressive Personality DisorderCase-Control StudiesGamblingGambling disorderFemale0305 other medical sciencePsychologyGambling disorder Dropout Treatment outcome Personality disorders Clinical syndromes Psychiatric disorders Disordered gambling Pathological gamblingClinical psychology
researchProduct

Deflazacort in Duchenne dystrophy: Study of long-term effect

1994

A randomized double-blind controlled trial of deflazacort was conducted in 28 Duchenne muscular dystrophy patients either treated with deflazacort 2.0 mg/kg alternate-day therapy or placebo. The deflazacort group showed significant improvement in climbing stairs (P < 0.01), in rising from a chair, Gower's maneuver, and walking (P < 0.0025) after 6 months of treatment. After 1 year, all the above changes remained significantly improved and the MRC index was significantly better (P < 0.05) in the treated group. After 2 years, a significant change was found in the MRC index: higher scores in walking, chair rising (P < 0.02), and grade and time of Gower's maneuver (P < 0.05) were found. The mea…

medicine.medical_specialtyPatient DropoutsTime Factorsmedicine.drug_classPhysiologyDuchenne muscular dystrophymedicine.medical_treatmentMotor ActivityPlaceboMuscular Dystrophieslaw.inventionCellular and Molecular NeuroscienceDouble-Blind MethodRandomized controlled trialPregnenedioneslawPhysiology (medical)medicineHumansChildGaitChemotherapybusiness.industryMusclesAnti-Inflammatory Agents Non-SteroidalBody Weightmedicine.diseaseSurgeryClinical trialDeflazacortAnesthesiaCorticosteroidNeurology (clinical)medicine.symptombusinessWeight gainFollow-Up Studiesmedicine.drugMuscle &amp; Nerve
researchProduct

Dropout from exercise randomized controlled trials among people with depression: A meta-analysis and meta regression

2015

Abstract Objective Exercise has established efficacy in improving depressive symptoms. Dropouts from randomized controlled trials (RCT’s) pose a threat to the validity of this evidence base, with dropout rates varying across studies. We conducted a systematic review and meta-analysis to investigate the prevalence and predictors of dropout rates among adults with depression participating in exercise RCT’s. Method Three authors identified RCT’s from a recent Cochrane review and conducted updated searches of major electronic databases from 01/2013 to 08/2015. We included RCT’s of exercise interventions in people with depression (including major depressive disorder (MDD) and depressive symptoms…

medicine.medical_specialtyPatient DropoutseducationDepression Exercise Physical activity DropoutPsychological interventionlaw.inventionRandomized controlled triallawPrevalencemedicineHumansMeta-regressionExerciseDepression (differential diagnoses)Dropout (neural networks)Randomized Controlled Trials as TopicDepressive Disorder MajorDepressive DisorderDepressionPhysical activityDropoutMajormedicine.diseaseExercise TherapyPsychiatry and Mental healthClinical PsychologyMeta-analysisPhysical therapyMajor depressive disorderDepression; Dropout; Exercise; Physical activity; Depression; Depressive Disorder Major; Humans; Patient Dropouts; Prevalence; Randomized Controlled Trials as Topic; Exercise Therapy; Psychiatry and Mental Health; Clinical PsychologyExercise prescriptionPsychology
researchProduct